Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(75.0%)

Early Phase 1

1(12.5%)

Phase 3

1(12.5%)

8Total

N/A(6)

Early Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00858351Not ApplicableCompleted

Thermal Biofeedback for the Treatment of Diabetic Neuropathy

Role: collaborator

NCT03134950Not ApplicableCompleted

Improving Care for Youth With FAP: A Stepped Care CBT Delivery Approach

Role: collaborator

NCT04095650Not ApplicableCompleted

A New Model to Reach Vulnerable Older Adults With Pain Self-management Support

Role: collaborator

NCT00677911Early Phase 1Completed

Immunologic Response to Negative Cognition in Persons With Chronic Pain

Role: collaborator

NCT02681081Not ApplicableCompleted

Optimizing Chronic Pain Treatment With Enhanced Neuroplastic Responsiveness

Role: collaborator

NCT02478437Phase 3Completed

A Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for theTreatment of Lumbar Facet Syndrome

Role: collaborator

NCT02164630Not ApplicableCompleted

Optimizing Resilience In Orofacial Pain and Nociception

Role: collaborator

NCT01327326Not ApplicableWithdrawn

Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain

Role: collaborator

All 8 trials loaded